Results 291 to 300 of about 488,008 (333)

Retraction: Protective effect of tanshinone IIA against cardiac hypertrophy in spontaneously hypertensive rats through inhibiting the Cys-C/Wnt signaling pathway. [PDF]

Oncotarget
Feng J, Chen HW, Pi LJ, Wang J, Zhan DQ.
europepmc   +1 more source

Non-muscle myosin IIC predominantly expressed in the slow-twitch skeletal muscles impedes age-related muscle weakness. [PDF]

PLoS One
Hamaguchi H, Hiraoka S, Tang K, Zhu H, Mita Y, Furuichi Y, Fujii NL, Manabe Y.   +7 more
europepmc   +1 more source

Delayed Discovery and Repair of a Traumatic Arteriovenous Fistula (AVF) 58 Years After a Combat Explosion. [PDF]

Cureus
Nagra R, Kanan MF, Martin J, Serban R, Packianathan XR.   +4 more
europepmc   +1 more source

First-PrinciplesPrediction of Two-Dimensional BeAllotropes and Alkaline-Earth Analogues (Mg, Ca, Sr, and Ba): fromHexagonal 2D Beryllenes to IIA Xenes

Heng Zhang (320479), Frédéric Guégan (8665962), Sylvain Pitié (12010033), Busheng Wang (8665956), Congxin Xia (3188049), Gilles Frapper (1638628)   +5 more
openalex   +1 more source

Molecular Signature in Focal Cortical Dysplasia: A Systematic Review of RNA and Protein Data. [PDF]

Int J Mol Sci
Shakerzadeh J, Jaroušek R, Goliášová Z, Brázdil M.   +3 more
europepmc   +1 more source

Ten-year follow-up outcomes of resected stage II non-small cell lung cancer patients. [PDF]

J Thorac Dis
Sun W, Li D, Yan Y, Han H, Bai J, Ma Z, Fu F, Zhang Y, Chen H.   +8 more
europepmc   +1 more source

D-brane Interactions in the IIA Plane-Wave Background

, 2004
Yeonjung Kim, Jaemo Park
openalex   +1 more source

Correction to "Radix <i>Salvia miltiorrhiza</i> for Ankylosing Spondylitis: Determining Potential Inflammatory Molecular Targets and Mechanism Using Network Pharmacology". [PDF]

Biomed Res Int
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Oral IIa Inhibitors

Hematology/Oncology Clinics of North America, 2010
Direct oral factor IIa inhibitors represent a new class of anticoagulants for the prevention and treatment of venous and selected arterial thomboembolisms. Dabigatran etexilate is the most studied and promising of the oral direct thrombin inhibitors. Preclinical and early-phase clinical studies show it to have a predictable and reliable pharmacokinetic
Catherine J, Lee, Gauri, Badhwar, Jack E, Ansell   +2 more
openaire   +2 more sources